American journal of surgery · 2026
The hidden costs of choice: Increased postoperative risks in patient-preference mastectomy for breast cancer.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Claire, Warburton Rebecca, Deban Melina, Newman-Bremang Jieun, Pao Jin-Si, Dingee Carol K, Bazzarelli Amy, Isaac Kathryn V, McKevitt Elaine C
Аннотация
BACKGROUND: Mastectomy rates for early-stage breast cancer have risen, yet no data currently differentiate complication risks across breast-conserving surgery (BCS), medically-necessary mastectomy (Mast-MN), and patient-preference mastectomy (Mast-PP). This study compared 30-day complications by procedure.
METHODS: Patients were prospectively enrolled. Mastectomy indication was coded preoperatively as Mast-MN when BCS was contraindicated, and Mast-PP when chosen despite BCS feasibility. 30-day complications were recorded and graded using the Clavien-Dindo system.
RESULTS: Among 929 patients (640 BCS, 202 Mast-MN, 87 Mast-PP), complication rates were 9.5%, 14.4%, and 24.1%; major complication occurred in 1.3%, 5.9%, and 13.8%, respectively. Mast-PP had higher odds of complications versus BCS (OR 2.7, 95% CI: 1.4 - 5.1). Both Mast-PP (OR 9.3, 95% CI: 3.3 - 26.0) and Mast-MN (OR 4.1, 95% CI: 1.6 - 10.9) increased odds of major complications.
CONCLUSION: Mast-PP carries higher overall and major complication risk than BCS, likely driven by reconstruction, underscoring the need for informed preoperative counseling.
METHODS: Patients were prospectively enrolled. Mastectomy indication was coded preoperatively as Mast-MN when BCS was contraindicated, and Mast-PP when chosen despite BCS feasibility. 30-day complications were recorded and graded using the Clavien-Dindo system.
RESULTS: Among 929 patients (640 BCS, 202 Mast-MN, 87 Mast-PP), complication rates were 9.5%, 14.4%, and 24.1%; major complication occurred in 1.3%, 5.9%, and 13.8%, respectively. Mast-PP had higher odds of complications versus BCS (OR 2.7, 95% CI: 1.4 - 5.1). Both Mast-PP (OR 9.3, 95% CI: 3.3 - 26.0) and Mast-MN (OR 4.1, 95% CI: 1.6 - 10.9) increased odds of major complications.
CONCLUSION: Mast-PP carries higher overall and major complication risk than BCS, likely driven by reconstruction, underscoring the need for informed preoperative counseling.